Skip to main content
Top
Published in: The Journal of Headache and Pain 1/2014

Open Access 01-12-2014 | Case report

Prolonged acute migraine with aura and reversible brain MRI abnormalities after liquid sclerotherapy

Authors: Yassine Zouitina, Mathilde Terrier, Marie Hyra, Djohar Seryer, Jean-Marc Chillon, Jean-Marc Bugnicourt

Published in: The Journal of Headache and Pain | Issue 1/2014

Login to get access

Abstract

Transient visual disturbances constitute the most commonly reported neurological side effect during and immediately after sclerotherapy. A few studies, based on clinical and diffusion-weighted MRI assessments, have suggested that these transient neurological symptoms correspond to migraine with aura. Recently, it has been reported that brain magnetic resonance imaging can reveal transient T2*-weighted abnormalities during the acute phase of migraine with aura. We reported a 36-year-old man who presented with transient neurological symptoms and concomitant T2*-weighted abnormalities on brain magnetic resonance imaging immediately after liquid sclerotherapy. We hypothesize that the reversible nature of the patient’s T2*-weighted abnormalities may indicate a relationship with the post-sclerotherapy migraine with aura attack.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C: Systematic review of foam sclerotherapy for varicose veins. BJS 2007, 94: 925–936. 10.1002/bjs.5891CrossRef Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C: Systematic review of foam sclerotherapy for varicose veins. BJS 2007, 94: 925–936. 10.1002/bjs.5891CrossRef
2.
go back to reference Guex JJ, Allaert FA, Gillet JL, Chleir F: Immediate and mid-term complications of sclerotherapy: report of a prospective multi-centric registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005, 31: 123–128.CrossRefPubMed Guex JJ, Allaert FA, Gillet JL, Chleir F: Immediate and mid-term complications of sclerotherapy: report of a prospective multi-centric registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005, 31: 123–128.CrossRefPubMed
3.
go back to reference Ratinahirana H, Benigni JP, Bousser MG: Injection of polidocanol foam in varicose veins as a trigger for attacks of migraine with aura. Cephalalgia 2003, 23: 850–885. 10.1046/j.1468-2982.2003.00548.xCrossRefPubMed Ratinahirana H, Benigni JP, Bousser MG: Injection of polidocanol foam in varicose veins as a trigger for attacks of migraine with aura. Cephalalgia 2003, 23: 850–885. 10.1046/j.1468-2982.2003.00548.xCrossRefPubMed
4.
go back to reference Coleridge SP: Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006, 32: 577–583. 10.1016/j.ejvs.2006.04.033CrossRef Coleridge SP: Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006, 32: 577–583. 10.1016/j.ejvs.2006.04.033CrossRef
5.
go back to reference Gillet JL, Donnet A, Lausecker M, Guedes JM, Guex JJ, Lehmann P: Pathophysiology of visual disturbances occurring after foam sclerotherapy. Phlebology 2010, 25: 261–266. 10.1258/phleb.2009.009068CrossRefPubMed Gillet JL, Donnet A, Lausecker M, Guedes JM, Guex JJ, Lehmann P: Pathophysiology of visual disturbances occurring after foam sclerotherapy. Phlebology 2010, 25: 261–266. 10.1258/phleb.2009.009068CrossRefPubMed
6.
go back to reference Karaarslan E, Ulus S, Kürtüncü M: Susceptibility-weighted imaging in migraine with aura. Am J Neuroradiol 2011, 32: e5-e7.PubMed Karaarslan E, Ulus S, Kürtüncü M: Susceptibility-weighted imaging in migraine with aura. Am J Neuroradiol 2011, 32: e5-e7.PubMed
7.
go back to reference Shimoda Y, Kudo K, Kuroda S, Zaitsu Y, Fujinma N, Terae S, Sasaki M, Houkin K: Susceptibility weighted imaging and magnetic resonance angiography during migraine attack: a case report. Magn Reson Med Sci 2011, 10: 49–52. 10.2463/mrms.10.49CrossRefPubMed Shimoda Y, Kudo K, Kuroda S, Zaitsu Y, Fujinma N, Terae S, Sasaki M, Houkin K: Susceptibility weighted imaging and magnetic resonance angiography during migraine attack: a case report. Magn Reson Med Sci 2011, 10: 49–52. 10.2463/mrms.10.49CrossRefPubMed
8.
go back to reference Bugnicourt JM, Canaple S, Lamy C, Deramond H, Godefroy O: T2*-weighted findings in prolonged acute migraine aura. Chin Med J 2013, 126: 20. Bugnicourt JM, Canaple S, Lamy C, Deramond H, Godefroy O: T2*-weighted findings in prolonged acute migraine aura. Chin Med J 2013, 126: 20.
9.
go back to reference Breu FX, Guggenbichler S: European consensus meeting on foam sclerotherapy. Dermatol Surg 2004, 30: 709–717. 10.1111/j.1524-4725.2004.30209.xCrossRefPubMed Breu FX, Guggenbichler S: European consensus meeting on foam sclerotherapy. Dermatol Surg 2004, 30: 709–717. 10.1111/j.1524-4725.2004.30209.xCrossRefPubMed
10.
go back to reference Kasner SE, Chalela JA, Luciano JM, Cucchiara BL, Raps EC, McGarvey ML, Conroy MB, Localio AR: Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke 1999, 30: 1534–1537. 10.1161/01.STR.30.8.1534CrossRefPubMed Kasner SE, Chalela JA, Luciano JM, Cucchiara BL, Raps EC, McGarvey ML, Conroy MB, Localio AR: Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke 1999, 30: 1534–1537. 10.1161/01.STR.30.8.1534CrossRefPubMed
11.
go back to reference Sarvananthan T, Shepherd AC, Willenberg T, Davies AH: Neurological complications of sclerotherapy for varicose veins. J Vasc Surg 2012, 55: 243–251. 10.1016/j.jvs.2011.05.093CrossRefPubMed Sarvananthan T, Shepherd AC, Willenberg T, Davies AH: Neurological complications of sclerotherapy for varicose veins. J Vasc Surg 2012, 55: 243–251. 10.1016/j.jvs.2011.05.093CrossRefPubMed
12.
go back to reference Gillet JL, Guedes JM, Guex JJ, Hamel-Desnos C, Schadeck M, Lauseker M, Allaert FA: Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009, 34: 131–138.CrossRef Gillet JL, Guedes JM, Guex JJ, Hamel-Desnos C, Schadeck M, Lauseker M, Allaert FA: Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009, 34: 131–138.CrossRef
13.
go back to reference International Headache Society Classification Subcommittee: International classification of headache disorders, 2nd edition. Cephalalgia 2004, 24(suppl 1):1–160. International Headache Society Classification Subcommittee: International classification of headache disorders, 2nd edition. Cephalalgia 2004, 24(suppl 1):1–160.
14.
go back to reference Viana M, Sprenger T, Andelova M, Goadsby PJ: The typical duration of migraine aura: a systematic review. Cephalalgia 2013, 33: 483–490. 10.1177/0333102413479834CrossRefPubMed Viana M, Sprenger T, Andelova M, Goadsby PJ: The typical duration of migraine aura: a systematic review. Cephalalgia 2013, 33: 483–490. 10.1177/0333102413479834CrossRefPubMed
15.
go back to reference Headache Classification Committee of the International Headache Society: The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013, 33: 629–808.CrossRef Headache Classification Committee of the International Headache Society: The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013, 33: 629–808.CrossRef
16.
go back to reference Schoene J, Sandor PS: Headache with focal neurological signs or symptoms: a complicated differential diagnosis. Lancet Neurol 2004, 3: 237–245. 10.1016/S1474-4422(04)00709-4CrossRef Schoene J, Sandor PS: Headache with focal neurological signs or symptoms: a complicated differential diagnosis. Lancet Neurol 2004, 3: 237–245. 10.1016/S1474-4422(04)00709-4CrossRef
17.
go back to reference Dreier JP, Kleeberg J, Petzold G, Priller J, Windmüller O, Orzechowski HD, Lindauer U, Heinemann U, Einhäupl KM, Dirnagl U: Endothelin-1 potently induces Lea˜o’s cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura? Brain 2002, 125: 102–112. 10.1093/brain/awf007CrossRefPubMed Dreier JP, Kleeberg J, Petzold G, Priller J, Windmüller O, Orzechowski HD, Lindauer U, Heinemann U, Einhäupl KM, Dirnagl U: Endothelin-1 potently induces Lea˜o’s cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura? Brain 2002, 125: 102–112. 10.1093/brain/awf007CrossRefPubMed
18.
go back to reference Zagami AS, Goadsby PJ, Edvinsson L: Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 1990, 16: 69–75. 10.1016/0143-4179(90)90114-ECrossRefPubMed Zagami AS, Goadsby PJ, Edvinsson L: Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 1990, 16: 69–75. 10.1016/0143-4179(90)90114-ECrossRefPubMed
19.
go back to reference Frullini A, Felice F, Burchielli S, Di Stefano R: High production of endothelin after foam sclerotherapy: a new pathogenetic hypothesis for neurological and visual disturbances after sclerotherapy. Phlebology 2011, 26: 203–208. 10.1258/phleb.2010.010029CrossRefPubMed Frullini A, Felice F, Burchielli S, Di Stefano R: High production of endothelin after foam sclerotherapy: a new pathogenetic hypothesis for neurological and visual disturbances after sclerotherapy. Phlebology 2011, 26: 203–208. 10.1258/phleb.2010.010029CrossRefPubMed
20.
go back to reference Lemos C, Neto JL, Pereira-Monteiro J, Mendonça D, Barros J, Sequeiros J, Alonso I, Sousa A: A role for endothelin receptor type A in migraine without aura susceptibility? A study in Portuguese patients. Eur J Neurol 2011, 18: 649–655. 10.1111/j.1468-1331.2010.03239.xCrossRefPubMed Lemos C, Neto JL, Pereira-Monteiro J, Mendonça D, Barros J, Sequeiros J, Alonso I, Sousa A: A role for endothelin receptor type A in migraine without aura susceptibility? A study in Portuguese patients. Eur J Neurol 2011, 18: 649–655. 10.1111/j.1468-1331.2010.03239.xCrossRefPubMed
Metadata
Title
Prolonged acute migraine with aura and reversible brain MRI abnormalities after liquid sclerotherapy
Authors
Yassine Zouitina
Mathilde Terrier
Marie Hyra
Djohar Seryer
Jean-Marc Chillon
Jean-Marc Bugnicourt
Publication date
01-12-2014
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 1/2014
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-15-41

Other articles of this Issue 1/2014

The Journal of Headache and Pain 1/2014 Go to the issue